Oleguer Parés‐Badell

Immunogenicity and reactogenicity of BNT162b2 booster in ChAdOx1-S-primed participants (CombiVacS): a multicentre, open-label, randomised, controlled, phase 2 trial

Alberto M. Borobia, Antonio J. Carcas, Mayte Pérez‐Olmeda et al. · The Lancet · 2021 · 384 citations · Full text

Suicidal Thoughts and Behaviors Among First-Year College Students: Results From the WMH-ICS Project

Philippe Mortier, Randy P. Auerbach, Jordi Alonso et al. · Journal of the American Academy of Child & Adolescent Psychiatry · 2018 · 296 citations · Full text

Psychological Co-morbidities, Behavioral Sciences, Psychiatry +12

Impact of comorbidity on survival by tumour location: Breast, colorectal and lung cancer (2000–2014)

Oleguer Parés‐Badell, Marta Banqué, Francesc Macià et al. · Cancer Epidemiology · 2017 · 49 citations

Cancer Epidemiology, Medicine, Cancer Recurrence +10

Drug consumption rooms in Catalonia: A comprehensive evaluation of social, health and harm reduction benefits

Cinta Folch, Nicolas Lorente, Xavier Majó et al. · International Journal of Drug Policy · 2018 · 31 citations

Substance Abuse, Preventive Medicine, Substance Use +13

Undiagnosed HIV and Hepatitis C infection in people who inject drugs: From new evidence to better practice

Oleguer Parés‐Badell, Albert Espelt, Cinta Folch et al. · Journal of Substance Abuse Treatment · 2017 · 17 citations

Hepatitis C, Treatment And Prevention, Viral Hepatitis +6